Albemarle Pref A ADR: KDJ Golden Cross, Bullish Marubozu on 15min Chart

According to Albemarle Pref A ADR's 15-minute chart, a golden cross has been detected, indicating a shift in the momentum of the stock price towards an upward trend. This bullish Marubozu pattern, observed at 10:45 on October 20, 2025, suggests that buyers are in control of the market and are likely to continue driving the stock price higher. As a result, there is potential for further increase in the stock price.

Agilent Technologies, Inc. (NYSE:A) reported strong earnings for the latest quarter, meeting analysts' expectations with earnings per share (EPS) of $1.37. Revenue increased by 10.1% year-over-year to $1.74 billion, according to a MarketBeat filing. The company also announced a quarterly dividend of $0.248 per share, with an annualized yield of 0.7%.

Concurrent Investment Advisors LLC recently purchased 2,260 shares of Agilent Technologies, valued at approximately $267,000, as reported in its most recent Form 13F filing. This move follows similar actions by other hedge funds, including Stone House Investment Management LLC, Ransom Advisory Ltd, Central Pacific Bank Trust Division, Zions Bancorporation National Association UT, and Costello Asset Management INC, which bought new positions in Agilent Technologies during the first and second quarters.

Analysts have shown increased interest in Agilent Technologies. Weiss Ratings reaffirmed a "hold (c)" rating, while Rothschild Redb raised the stock to a "strong-buy" rating, and Wall Street Zen upgraded it from "hold" to "buy." Barclays lifted their price target to $150.00 and gave the stock an "equal weight" rating, and UBS Group upgraded from "neutral" to "buy" and increased their price target to $170.00. The average rating among analysts is "Moderate Buy," with a consensus price target of $149.62.

Agilent Technologies provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide, operating in segments including Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The company's financial health, as reflected in its debt-to-equity ratio of 0.53, quick ratio of 1.71, and current ratio of 2.25, indicates robust liquidity.

As of September 12, 2025, Agilent Technologies has a market capitalization of $40.26 billion, a P/E ratio of 33.34, a PEG ratio of 4.63, and a beta of 1.26. The stock has a 1-year low of $96.43 and a 1-year high of $153.84. The company has set its FY 2025 guidance at 5.560-5.590 EPS and Q4 2025 guidance at 1.570-1.600 EPS.